It's important to follow the dosing instructions carefully and use the provided measuring device to ensure the correct amount is taken
It contains no added sugar and is free of artificial sweeteners, synthetic colors, or dyes
The SUSTAIN-6 Trial (Once-Weekly Semaglutide) The Trial to Evaluate Cardiovascular and Other Long-term Outcomes with Semaglutide in Subjects with Type 2 Diabetes (SUSTAIN-6) consisted of 3297 people living with T2DM, 83% with established cardiovascular disease, receiving once-weekly semaglutide (0.5 and 1.0 mg) or placebo
Switching is appropriate for inadequate weight loss, insurance coverage change, or persistent side effects
Product Overview Content: 50 mg per vial Form: Lyophilized peptide powder Appearance: White to off-white powder or solid cake Container: Sterile, sealed research vial Research Description Retatrutide is investigated for its interaction with multiple metabolic signaling pathways, including receptors associated with energy balance, glucose regulation, and appetite signaling